American society of clinical oncology 2012 annual meeting: highlights from the gynecologic oncology track.
Int. J. Gynecol. Cancer., Nov;22(9):1634-9 (2012)
Advanced cytoreductive surgery workshop report.
Int. J. Gynecol. Cancer., Nov;22(9):1604-10 (2012)
Emerging treatment options for management of malignant ascites in patients with ovarian cancer.
Int J Womens Health., 4:395-404 (2012)
Outcomes of High-Dose-Rate Interstitial Brachytherapy in the Treatment of Locally Advanced Cervical Cancer: Long-term Results.
Int. J. Radiat. Oncol. Biol. Phys., Jul (2012)
The challenge of follow-up in a low-income colposcopy clinic: characteristics associated with noncompliance in high-risk populations.
J Low Genit Tract Dis., Oct;16(4):345-51 (2012)
Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study.
Gynecol. Oncol., Apr;125(1):87-93 (2012)
Role of canonical Wnt signaling in endometrial carcinogenesis.
Expert Rev Anticancer Ther., Jan;12(1):51-62 (2012)
American Society of Clinical Oncology 2011 Annual Meeting update: summary of selected gynecologic cancer abstracts.
Gynecol. Oncol., Aug;122(2):209-12 (2011)
Fertility preserving options in patients with gynecologic malignancies.
Am. J. Obstet. Gynecol., Aug;205(2):103-10 (2011)
Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation
Gynecol. Oncol., Dec;119(3):444-50 (2010)
Drug discovery in ovarian cancer.
Recent Pat Anticancer Drug Discov., Nov;5(3):251-60 (2010)
Recombination of human papillomavirus-16 and host DNA in exfoliated cervical cells: a pilot study of L1 gene methylation and chromosomal integration as biomarkers of carcinogenic progression.
J. Med. Virol., Feb;82(2):311-20 (2010)
Pelvic radiation improves local control after hysterectomy for uterine leiomyosarcoma: a 20-year experience.
Int. J. Gynecol. Cancer., Aug;19(6):1080-4 (2009)
Beyond platinum for metastatic and recurrent carcinoma of the cervix.
Onkologie., Oct;32(10):552-4 (2009)
Socioeconomic factors may contribute to neoadjuvant chemotherapy use in metastatic epithelial ovarian carcinoma.
Gynecol. Oncol., Dec;115(3):339-42 (2009)
Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the Gynecologic Oncology Group.
Semin. Oncol., Apr;36(2):170-80 (2009)
Green tea catechins for treatment of external genital warts.
Am. J. Obstet. Gynecol., Mar;200(3):233.e1-7 (2009)
A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gynecol. Oncol., Jan;112(1):85-9 (2009)
Cervical neoplasia in pregnancy. Part 1: screening and management of preinvasive disease.
Am. J. Obstet. Gynecol., Jul;199(1):3-9 (2008)
The influence of conservative surgical practices for malignant ovarian germ cell tumors.
J Surg Oncol., Aug;98(2):111-6 (2008)
The spectrum and clinical sequelae of human papillomavirus infection.
Gynecol. Oncol., Nov;107(2 Suppl 1):S6-13 (2007)
Supportive care for women with gynecologic cancers.
Expert Rev Anticancer Ther., Feb;8(2):227-41 (2008)
Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions.
J. Clin. Oncol., Jul;25(20):2952-65 (2007)
Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer.
Curr Oncol Rep., Nov;7(6):419-34 (2005)
Conservation of in vitro drug resistance patterns in epithelial ovarian carcinoma.
Gynecol. Oncol., Sep;98(3):360-8 (2005)
Surgical cytoreduction and hormone therapy of an advanced endometrial stromal sarcoma of the ovary.
Obstet Gynecol., May;103(5 Pt 2):1051-4 (2004)